Impact Factor

2.6

Global Health & Medicine -> 2020 Vol.2(No.5)

Editorial
What liver surgeons have achieved in the recent decade for patients with hepatocellular carcinoma?
Global Health & Medicine. 2020; 2(5):265-268.
Clinical implications of WNT/β-catenin signaling for hepatocellular carcinoma
Global Health & Medicine. 2020; 2(5):269-272.
Review
Hepatocyte ploidy and pathological mutations in hepatocellular carcinoma: impact on oncogenesis and therapeutics
Global Health & Medicine. 2020; 2(5):273-281.
Difference in treatment algorithms for hepatocellular carcinoma between world's principal guidelines
Global Health & Medicine. 2020; 2(5):282-291.
Effects of volume on outcome in hepatobiliary surgery: a review with guidelines proposal
Global Health & Medicine. 2020; 2(5):292-297.
Simulation and navigation liver surgery: an update after 2,000 virtual hepatectomies
Global Health & Medicine. 2020; 2(5):298-305.
Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China
Global Health & Medicine. 2020; 2(5):306-311.
An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system
Global Health & Medicine. 2020; 2(5):312-318.
Original Article
Early hemodynamics of hepatocellular carcinoma using contrastenhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases
Global Health & Medicine. 2020; 2(5):319-327.
Definition of the caudate lobe of the liver based on portal segmentation
Global Health & Medicine. 2020; 2(5):328-336.
Liver resections between 2014 and 2020 in the Lausanne University Hospital, Switzerland
Global Health & Medicine. 2020; 2(5):337-342.